An industry imperiled by regulatory bottlenecks

Nat Biotechnol. 2001 Aug;19(8):709-10. doi: 10.1038/90735.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biotechnology / legislation & jurisprudence*
  • Biotechnology / trends
  • Drug Industry / legislation & jurisprudence*
  • Drug Industry / trends*
  • Humans
  • Time Factors
  • United States
  • United States Food and Drug Administration